Latest market price
3.35
+0.00%
OverviewShort InterestFilings
XFORQT24X4 Pharmaceuticals, Inc.·NASDAQ
3.35+0.00%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 29, 20268-KCurrent report
Oct 19, 20264Statement of changes in beneficial ownership
Oct 08, 20268-KCurrent report
Oct 07, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 05, 20264Statement of changes in beneficial ownership
Sep 21, 2026SC 13GBeneficial ownership statement (passive)
Sep 09, 20268-KCurrent report
Sep 08, 20268-KCurrent report
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 20264Statement of changes in beneficial ownership
Aug 13, 20264Statement of changes in beneficial ownership
Aug 06, 202610-QQuarterly report
Jul 30, 2026SC 13GBeneficial ownership statement (passive)
Jul 01, 20268-KCurrent report
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20263Initial statement of beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 2026EFFECTNotice of effectiveness
May 13, 20268-K/ACurrent report (amended)
May 13, 20264Statement of changes in beneficial ownership
May 12, 20268-KCurrent report
May 06, 2026S-3Shelf registration statement
May 06, 202610-QQuarterly report
#1 / 25 of 408
Page
▼
/ 17